FDA Drug Recalls

Delsam Pharma Artificial Eye Ointment has issued a voluntary nationwide recall of Artificial Eye Ointment Batch No. H29. The Ointment was distributed to the consumer level through Delsam Pharma. The products could contain microbial contamination and possible product package leaking or compromised. Risk Statement Using contaminated ointment can cause eye infections that could lead to

Apotex Corp. is issuing a voluntary nationwide recall of six (6) lots of Brimonidine Tartrate Ophthalmic Solution, 0.15%. The consumer-level recall was initiated with an abundance of caution after some units of Brimonidine tartrate ophthalmic solution bottles developed cracks on the caps. Brimonidine Tartrate Ophthalmic Solution is indicated to lower intraocular pressure in patients with

nanoMaterials Discovery Corporation issues a voluntary nationwide recall of its Alcohol Antiseptic 80% Alcohol Solution. The consumer-level recall affects all lots of the products branded “Snowy Range Blue” and packed in four fluid-ounce spray dispensers. The recall was initiated because certain batches of the product may exceed FDA’s recommended methanol limit. Risk Statement Alcohol Antiseptic

Vold Candy issues a consumer-level recall of PrimeZen Black 6000, 2000 mg capsule. The recall is being initiated after FDA analysis found that PrimeZen Black 6000 capsules of sildenafil & tadalafil. Sildenafil and tadalafil are phosphodiesterase (PDE-5) inhibitors only found in FDA-approved drugs for erectile dysfunction. Therefore, the presence of these inhibitors in the recalled

IBSA Pharma Inc. has issued a voluntary recall of 27 lots of TIROSINT®-SOL (levothyroxine sodium) Oral Solution. The consumer-level recall was initiated after the company analysis revealed the possible subpotency of these products. The analysis showed that some lots decreased below 95.0% of their labelled amount in levothyroxine sodium (T4). Risk Statement If patients under